Former NCCAM director now consulting
This article was originally published in The Tan Sheet
Tampa-Fla. based Calgenex Corporation announces Sept. 14 Joseph Jacobs, MD, has joined the company as Consulting Medical Director. Jacobs, the first director of what it is now NCCAM, joins the firm to fight the effects of soft tissue calcification and inflammation, the firm says. "I think the folks at Calganex are onto something very exciting that may improve the lives of millions," Jacobs says. Calganex CEO and President Grant Carlson says, "As a consulting medical director he will help guide the clinical development of our products and communicate our message to both the medical community and the general public." Jacobs received his medical degree from Yale University and completed his residency at Dartmouth-Hitchcock Medical Center. Calganex was founded in February 2006...
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.